pharmaphorum July 20, 2022
Phil Taylor

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups.

London-based DSV has been working since 2019 with the charity’s Cancer Research Horizons unit, an incubator organisation which was set up to nurture new discoveries in academia and help to bring them to patients.

The organisation has been instrumental in the formation of more than 60 startups across cancer therapeutics, diagnostics and medtech, collectively raising more than £2.3 billion ($2.75 billion) since it was formed in the early 2000s.

DSV’s involvement will provide pre-seed capital for the new ventures, which will be incubated within Cancer Research Horizon’s wet labs with support from scientists among...

Today's Sponsors

Amwell
Oliver Wyman
Upfront Healthcare

Today's Sponsors

Qure4u
H1

Today's Sponsor

HealthITq

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
DispatchHealth, Home Instead Form Partnership To Deliver In-Home Acute Care
Humana adding value-based kidney care partnership
Innovative Partnerships Power Mobile Integrated Health Programs
How Health System Staffing Partnerships Are Meeting Ever-Changing Needs
Less can be more: New considerations for hospital and health system partnerships